Drug Safety

A Benefit-Risk Assessment of Inhaled Long-Acting β₂-Agonists in the Management of Obstructive Pulmonary Disease
pp. 689-715(27)
Authors: Sovani, Milind P.; Whale, Christopher I.; Tattersfield, Anne. E.

Comparative Tolerability of Drug Treatment for Nocturnal Enuresis in Children
pp. 717-727(11)
Authors: Müller, Dominik; Roehr, Charles C.; Eggert, Paul

Calculation of Doses of Drugs in Solution: Are Medical Students Confused by Different Means of Expressing Drug Concentrations?
pp. 729-734(6)
Authors: Wheeler, Daniel W.; Remoundos, Dionysios D.; Whittlestone, Kim D.; House, Timothy P.; Menon, David K.

Safety Related Drug-Labelling Changes: Findings from Two Data Mining Algorithms
pp. 735-744(10)
Authors: Hauben, Manfred; Reich, Lester

Haematological Effects of Interferon-β-1a (Rebif^®) Therapy in Multiple Sclerosis
pp. 745-756(12)
Authors: Rieckmann, Peter; O'Connor, Paul; Francis, Gordon S.; Wetherill, Graham; Alteri, Enrica